Found: 6
Select item for more details and to access through your institution.
Octreotide long-acting repeatable and lanreotide Autogel are equally effective in controlling growth hormone secretion in acromegalic patients.
- Published in:
- European Journal of Endocrinology, 2004, v. 150, n. 4, p. 0489
- By:
- Publication type:
- Article
Quality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 6, p. 3279, doi. 10.1210/jc.2004-1375
- By:
- Publication type:
- Article
Homozygous and Heterozygous Expression of a Novel Insulin-Like Growth Factor-I Mutation.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 5, p. 2855, doi. 10.1210/jc.2004-1254
- By:
- Publication type:
- Article
Persistent diastolic dysfunction despite successful long-term octreotide treatment in acromegaly.
- Published in:
- European Journal of Endocrinology, 2005, v. 153, n. 2, p. 231, doi. 10.1530/eje.1.01955
- By:
- Publication type:
- Article
It takes acid, rather than ice, to freeze glucose.
- Published in:
- Scientific Reports, 2015, p. 8875, doi. 10.1038/srep08875
- By:
- Publication type:
- Article
Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients.
- Published in:
- Clinical Endocrinology, 2007, v. 66, n. 4, p. 489, doi. 10.1111/j.1365-2265.2006.02757.x
- By:
- Publication type:
- Article